Cargando…

Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review

BACKGROUND: Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oga-Omenka, Charity, Tseja-Akinrin, Azhee, Sen, Paulami, Mac-Seing, Muriel, Agbaje, Aderonke, Menzies, Dick, Zarowsky, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333807/ https://www.ncbi.nlm.nih.gov/pubmed/32616481 http://dx.doi.org/10.1136/bmjgh-2019-002280

Ejemplares similares

Commentary: Lessons from the COVID-19 global health response to inform TB case finding
por: Oga-Omenka, Charity, et al.
Publicado: (2021)

Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study
por: Oga-Omenka, Charity, et al.
Publicado: (2019)

Partnering with the private laboratories to strengthen TB diagnostics in Nigeria
por: Ali, Taofeekat, et al.
Publicado: (2023)

Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes
por: Oga-Omenka, Charity, et al.
Publicado: (2020)

Pro-equity legislation, health policy and utilisation of sexual and reproductive health services by vulnerable populations in sub-Saharan Africa: a systematic review
por: Mac-Seing, Muriel, et al.
Publicado: (2020)

A qualitative meta-synthesis of facilitators and barriers to tuberculosis diagnosis and treatment in Nigeria
por: Oga-Omenka, Charity, et al.
Publicado: (2021)

Understanding the gaps in DR-TB care cascade in Nigeria: A sequential mixed-method study
por: Oga-Omenka, Charity, et al.
Publicado: (2020)

Effectiveness of interventions based on patient empowerment in the control of type 2 diabetes in sub‐Saharan Africa: A review of randomized controlled trials
por: Mogueo, Amélie, et al.
Publicado: (2020)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

TB and COVID – Public and private health sectors adapt to a new reality
por: Klinton, Joel Shyam, et al.
Publicado: (2020)

Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China
por: Zhao, Bing, et al.
Publicado: (2022)

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis
por: Reuter, Anja, et al.
Publicado: (2023)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Disability and sexual and reproductive health service utilisation in Uganda: an intersectional analysis of demographic and health surveys between 2006 and 2016
por: Mac-Seing, Muriel, et al.
Publicado: (2022)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide
por: Ngabonziza, Jean Claude Semuto, et al.
Publicado: (2017)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Four months of rifampicin monotherapy for latent tuberculosis infection in children
por: Oh, Chi Eun, et al.
Publicado: (2021)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022)

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
por: Nordqvist, H., et al.
Publicado: (2016)

Surveillance of multidrug-resistant tuberculosis in sub-Saharan Africa through wastewater-based epidemiology
por: Mtetwa, Hlengiwe N., et al.
Publicado: (2023)

How to navigate the application of ethics norms in global health research: reflections based on qualitative research conducted with people with disabilities in Uganda
por: Mac-Seing, Muriel, et al.
Publicado: (2021)

Policy Implementation Challenges and Barriers to Access Sexual and Reproductive Health Services Faced By People With Disabilities: An Intersectional Analysis of Policy Actors’ Perspectives in Post-Conflict Northern Uganda
por: Mac-Seing, Muriel, et al.
Publicado: (2021)

Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
por: Tembo, Blackson Pitolo, et al.
Publicado: (2019)

Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients
por: Gomathi, N.S., et al.
Publicado: (2020)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China
por: Fang, Mu-Tong, et al.
Publicado: (2021)

Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis
por: Choi, Hongjo, et al.
Publicado: (2023)

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
por: Ragonnet, Romain, et al.
Publicado: (2017)

Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains
por: Machado, Diana, et al.
Publicado: (2018)

Rifampicin-Resistant Multidrug-Resistant Tuberculosis Cases in Selected Hospitals in Western Oromia, Ethiopia: Cross-Sectional Retrospective Study
por: Zewdie, Olifan, et al.
Publicado: (2020)

The intersectional jeopardy of disability, gender and sexual and reproductive health: experiences and recommendations of women and men with disabilities in Northern Uganda
por: Mac-Seing, Muriel, et al.
Publicado: (2020)

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2019)

Factors Associated with Non-Adherence for Prescribed Treatment in 201 Patients with Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in Anhui Province, China
por: Zhu, Qing-Qing, et al.
Publicado: (2022)

Finding the missing millions: lessons from 10 active case finding interventions in high tuberculosis burden countries
por: Pande, Tripti, et al.
Publicado: (2020)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study
por: Souhail, Dahraoui, et al.
Publicado: (2016)

Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa
por: Loveday, Marian, et al.
Publicado: (2020)

Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study
por: Tesfamariam, Sirak, et al.
Publicado: (2021)

Dioctanoyl Ultrashort Tetrabasic β-Peptides Sensitize Multidrug-Resistant Gram-Negative Bacteria to Novobiocin and Rifampicin
por: Ramirez, Danyel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q1pg72k2r59ejs1imknb3v5esq